title: FDA raises concerns about ultra-long acting insulins given green light in Europe and Japan.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Torjesen
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D017277:Drug Approval; D005060:Europe; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D049528:Insulin, Long-Acting / Q000009:adverse effects*; D007564:Japan; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting